Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss
Norimitsu Ban, Tae Jun Lee, Abdoulaye Sene, Mayur Choudhary, Michael Lekwuwa, Zhenyu Dong, Andrea Santeford, Jonathan B. Lin, Goldis Malek, Daniel S. Ory, Rajendra S. Apte
Norimitsu Ban, Tae Jun Lee, Abdoulaye Sene, Mayur Choudhary, Michael Lekwuwa, Zhenyu Dong, Andrea Santeford, Jonathan B. Lin, Goldis Malek, Daniel S. Ory, Rajendra S. Apte
View: Text | PDF
Research Article Ophthalmology

Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss

  • Text
  • PDF
Abstract

Advanced age-related macular degeneration (AMD), the leading cause of blindness among people over 50 years of age, is characterized by atrophic neurodegeneration or pathologic angiogenesis. Early AMD is characterized by extracellular cholesterol-rich deposits underneath the retinal pigment epithelium (RPE) called drusen or in the subretinal space called subretinal drusenoid deposits (SDD) that drive disease progression. However, mechanisms of drusen and SDD biogenesis remain poorly understood. Although human AMD is characterized by abnormalities in cholesterol homeostasis and shares phenotypic features with atherosclerosis, it is unclear whether systemic immunity or local tissue metabolism regulates this homeostasis. Here, we demonstrate that targeted deletion of macrophage cholesterol ABC transporters A1 (ABCA1) and -G1 (ABCG1) leads to age-associated extracellular cholesterol-rich deposits underneath the neurosensory retina similar to SDD seen in early human AMD. These mice also develop impaired dark adaptation, a cardinal feature of RPE cell dysfunction seen in human AMD patients even before central vision is affected. Subretinal deposits in these mice progressively worsen with age, with concomitant accumulation of cholesterol metabolites including several oxysterols and cholesterol esters causing lipotoxicity that manifests as photoreceptor dysfunction and neurodegeneration. These findings suggest that impaired macrophage cholesterol transport initiates several key elements of early human AMD, demonstrating the importance of systemic immunity and aging in promoting disease manifestation. Polymorphisms in genes involved with cholesterol transport and homeostasis are associated with a significantly higher risk of developing AMD, thus making these studies translationally relevant by identifying potential targets for therapy.

Authors

Norimitsu Ban, Tae Jun Lee, Abdoulaye Sene, Mayur Choudhary, Michael Lekwuwa, Zhenyu Dong, Andrea Santeford, Jonathan B. Lin, Goldis Malek, Daniel S. Ory, Rajendra S. Apte

×

Figure 2

Six-month-old Abca1/g1–m/–m retinas demonstrate decreased scotopic responses and impaired dark adaptation associated with disrupted RPE morphology and Bruch’s membrane thickening.

Options: View larger image (or click on image) Download as PowerPoint
Six-month-old Abca1/g1–m/–m retinas demonstrate decreased scotopic respo...
(A–C) ERG of 6-month-old Abca1/g1F/F (n = 4) and Abca1/g1–m/–m mice (n = 5). (A) Scotopic a-wave amplitude. (B) Scotopic b-wave amplitude. (C) Photopic b-wave amplitude. **P < 0.01 by 2-way ANOVA with post hoc Bonferroni’s multiple comparison test. (D) Dark adaptation curves of 6-month-old Abca1/g1F/F (n = 4) and Abca1/g1–m/–m mice (n = 8). *P < 0.05, **P < 0.01, and ***P < 0.001 by 2-way ANOVA with post hoc Bonferroni’s multiple comparison test. (E and F) Representative electron microscopy images of 6-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinal pigmented epithelium (RPE). (E) Illustration of dysmorphic changes in 6-month-old Abca1/g1F/F and Abca1/g1–m/–m mice RPE. Note the vacuoles (asterisks), photoreceptor disk fragments (yellow arrowhead), and lipid droplets (red arrowheads) in Abca1/g1–m/–m mice RPE. Scale bar: 1 μm. (F) Thickness change of 6-month-old Abca1/g1F/F (n = 6) and Abca1/g1–m/–m (n = 4) mice Bruch’s membrane (BrM). Note the white bars, which represent BrM thickness. Scale bar: 1 μm. (G) Quantification of BrM thickness. **P < 0.01 by 2-tailed unpaired t test. Values are mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts